2020 American Transplant Congress
Time for Change: Assessment of Renal Transplant Artery Stenosis with N.A.T.I.V.E. True-F.I.S.P. and N.A.T.I.V.E. G.R.E
*Purpose: Non-contrast MRA can be fraught with artifact and lack of signal both in areas of stenosis as well as normal vessels. Therefore, it is…2018 American Transplant Congress
De Novo DSA against Third Party Extension Vessels Used in Kidney and Pancreas Transplantation
University of Wisconsin, Madison.
Third party ABO-compatible vessel allografts (VA) are sometimes used as extension vessels for kidney and pancreas transplants (TX). The frequency and implications of de novo…2017 American Transplant Congress
Fibromuscular Dysplasia in Living Kidney Donors: Characteristics and Recipient Outcomes.
Introduction: Presence of incidentally detected fibromuscular dysplasia (FMD) is a challenging and controversial issue for selection of living kidney donors (LKD). Whether donors with FMD…2017 American Transplant Congress
Classification of Fibromuscular Dysplasia in Kidney Donors Based on Severity and Extent of Lesion.
Introduction: Selection of living kidney donors (LKD) with renal artery (RA) fibromuscular dysplasia (FMD) is controversial, as traditional diagnostic classifications lack estimates on FMD severity.…2017 American Transplant Congress
Endovascular Management of Transplant Renal Artery Stenosis: A Safe and Effective Treatment.
Background:Transplant Renal Artery Stenosis (TRAS) is a low incidence complication, but if untreated, can lead to graft failure, refractory hypertension (HT) and reduced life expectancy.…2017 American Transplant Congress
Inferior 10-Year Graft and Patient Survival After End-to-Side Reconstruction for Two Renal Arteries in Living Donor Renal Transplantation.
Purpose: Living donor kidneys with two arteries can be revascularized using various techniques depending on anatomy and surgeon preference. We hypothesized that the revascularization technique…2016 American Transplant Congress
Common Iliac Artery Stenosis: An Often Overlooked Cause of Graft Dysfunction.
Nephrology, University of Alberta, Edmonton, AB, Canada.
Transplant renal artery stenosis (TRAS) has been an increasingly recognized complication post kidney transplantation, and a potentially reversible cause for hypertension and allograft dysfunction. This…2016 American Transplant Congress
The UK Kidney Donor Risk Index Score Predicts the Development of TRAS Post Deceased Donor Transplantation.
Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.
Introduction: Transplant renal artery stenosis (TRAS) is a heterogeneous disorder with different subtypes and aetiologies, which include traditional cardiovascular and transplant specific risk factors. Whether…2016 American Transplant Congress
Renal Allograft Outcomes with Renal Artery Angioplasty and/or Stenting in Transplant Renal Artery Stenosis.
Background: The renal allograft function and blood pressure (BP) control after renal artery angioplasty±stenting for transplant renal artery stenosis (TRAS) is unclear. We aim to…2015 American Transplant Congress
CO2 Angiography Provides a Safe Alternative to Iodinated Contrast Agents in the Diagnosis and Endovascular Treatment of Transplant Renal Artery Stenosis
Background: Transplant Renal Artery Stenosis (TRAS) is a recognized complication resulting in graft dysfunction and post-transplant hypertension. Non-nephrotoxic imaging modalities such as ultrasonography are effective…
American Transplant Congress abstracts